Task: Translation
Input (English): The FDA has disagreed with the GAO's finding that the high-level management was more involved in processing this application and that the rationale offered was novel, despite acknowledging that the adolescent cognitive ability rationale was unprecedented in FDA practice.
Output (Japanese): FDAは、不完全な認識能力による根拠は、FDAの慣習に前例がないと認めたにも関わらず、GAOの高レベルの管理者がこの承認の処理により関与し、新薬という根拠を提示したという結論に反対した。